Open Access Fund

**Applications will be reviewed as they are submitted, until this funding is spent**


The VALIDATE Network aims to accelerate vaccine research and development for complex intracellular pathogens that cause diseases significant to low and middle-income countries (LMIC), with a focus on Mycobacterium tuberculosis, Leishmania spp, Burkholderia pseudomallei and Mycobacterium leprae. VALIDATE also aims to facilitate Continuing Professional Development (CPD) and career progression amongst its members.


To support these aims, VALIDATE has received funding to support LMIC members (Associates and early-PI Investigators) publishing original peer-reviewed articles in covering costs to make their publication open-access, as this has two main benefits:

  1. Increased visibility and citations of the article and its authors
  2. Access to the article for all VALIDATE members, disseminating information and widening access to VALIDATE-relevant research


Please see the our guidance document, below, about this award and how to apply. Please submit your application form and associated documents to the VALIDATE Network Manager at Do contact the Network Manager at the same address with any queries about the form or the application process.


Applications will be reviewed on a rolling basis, by the VALIDATE Management Team, within one month of submission, until the funding is spent


Application Documents

List of LMICs (all countries listed on this document count as 'LMIC')